(Press-News.org) PITTSBURGH, June 29, 2015 - The immune response that occurs in patients with severe asthma is markedly different than what occurs in milder forms of the lung condition, according to researchers from the University of Pittsburgh School of Medicine. Those unique features could point the way to new treatments, they said in an article published online today in the Journal of Clinical Investigation (JCI).
People with severe asthma, in which the airways become inflamed and constrict to impair breathing, do not get better even with high doses of corticosteroids, the mainstay of treatment for typical asthma, explained Anuradha Ray, Ph.D., professor of medicine, Pitt School of Medicine.
"About 10 percent of asthma patients have a severe form of the disease, but they account for up to half of asthma costs in the U.S. and Europe," Dr. Ray said. "That's because these patients frequently need to go to the emergency room or be hospitalized when they have an acute asthma episode."
For the study, conducted as part of the doctoral thesis of Mahesh Raundhal, a graduate student in the laboratory of Prabir Ray, Ph.D., Pitt professor of medicine and co-senior author, the research team examined lung cell samples obtained from patients also participating in the Severe Asthma Research Program (SARP), a National Heart, Lung, and Blood Institute of the National Institutes of Health-sponsored program to improve the understanding of severe asthma. Sally Wenzel, M.D., director of the University of Pittsburgh Asthma Institute of UPMC, serves as the Pitt SARP principal investigator.
Researchers observed that the immune cells, called CD4 T-cells, in the airways of severe asthmatics secreted different inflammatory proteins than those in mild disease, particularly interferon gamma. The analysis of human samples helped them to develop a mouse model of the disease by introducing an allergen and a bacterial product to induce an immune profile and airway hyper-reactivity that were poorly controlled by corticosteroids, comparable to human severe asthma patients.
When they subjected mice that lacked the interferon gamma gene to the severe asthma model, they found that the mice could not be induced to develop severe asthma. Using computer modeling to identify links between interferon gamma and asthma-associated genes, they learned that as interferon gamma levels rose, the levels of a protein called secretory leukocyte protease inhibitor (SLPI) dropped.
In follow-up experiments, the team found that boosting SLPI levels reduced airway hyper-reactivity in the animal model.
"We'd like to better understand why severe asthma occurs in most people right from the start," Dr. Anuradha Ray said. "We also want to find agents that can raise SLPI levels for clinical use."
In a new project that began this month, Drs. Anuradha Ray and Wenzel were recently awarded a five-year, $8 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), also part of the National Institutes of Health (NIH), to continue studying the immune response and genetic roots of severe asthma in 120 patients and in animal models.
The research effort signifies a union of Pitt and UPMC scientists, immunologists and clinicians working under the NIAID grant to bring bench to bedside and bedside to bench, Dr. Wenzel said.
"It's the unmet need of asthma," Dr. Wenzel said. "This is one of the first true opportunities to integrate top-tier immunologists with translational clinical science. To find the many different mechanisms involved, you need a team effort such as this one."
INFORMATION:
In addition to Drs. Wenzel and Anuradha Ray, the project leaders of this grant are core leaders Timothy B. Oriss, Ph.D., of the University of Pittsburgh, and Jay Kolls, M.D., of Children's Hospital of Pittsburgh of UPMC, who also co-authored the JCI paper. Other members of the research team are Prabir Ray, Ph.D., and Fernando Holguin, M.D., Douglas Landsittel, Ph.D., and Donald DeFranco, Ph.D., all of Pitt.
The published project was funded by NIH grants HL113956, Al106684, AI048927, AI100012, HL69174, HL079142, and DK072506; as well as the Cystic Fibrosis Foundation Research Development Program.
Contact: Chuck Finder
Phone: 412-996-5852
E-mail: FinderCE@upmc.edu
Contact: Anita Srikameswaran
Phone: 412-578-9193
E-mail: SrikamAV@upmc.edu
Baltimore, Md., June 29, 2015 - As the South Korean epidemic of Middle East Respiratory Syndrome (MERS) continues unabated, researchers have raced to find treatments for the deadly virus, which has killed more than 400 people since it was first discovered three years ago in Saudi Arabia.
Now, scientists at the University of Maryland School of Medicine and Regeneron Pharmaceuticals, Inc., have discovered and validated two therapeutics that show early promise in preventing and treating the disease, which can cause severe respiratory symptoms, and has a death rate of 40 ...
Alexandria, Va., USA - Today, the International and American Associations for Dental Research (IADR/AADR) published a case report on the first application of a 3D printed scaffold for periodontal tissue engineering in a human patient, along with a review of 3D printing for oral and craniofacial tissue engineering. These papers are published in the latest clinical supplement to the Journal of Dental Research, which encompasses all areas of clinical research in the dental, oral and craniofacial sciences, and brings emerging contributions in discovery and translational science ...
The goal for many cancer patients is to reach the five-year, disease-free mark, but new research from UR Medicine's Wilmot Cancer Institute suggests that two years might be a more practical survival goal for people with follicular lymphoma.
The difference underscores the fact that about 20 percent of follicular lymphoma patients consistently experience their disease coming back within two years of being treated with the latest therapies--despite the fact that most follicular lymphoma patients can expect to live 20 years.
People who relapse early may have a disease with ...
NEW YORK (29 June 2015) -- There has been much recent discussion in the press of the plight of the so-called "sandwich generation," that is, adults who are responsible for the care of children as well as aging parents. The need for simultaneous childcare and eldercare is a reality that can limit families'--particularly women's--opportunities for paying work.
A new study by social scientists Emilio Zagheni and Denys Dukhovnov for the first time drills down into US statistics about who is providing this care, and who is receiving it. The study found that in 2012, adults ...
WASHINGTON (June 29, 2015) -- As Liberia rebuilds a health care system decimated by the 2014 Ebola outbreak, understanding precisely how far citizens live from health facilities and its impact on seeking care can help shape new strategies to improve health care delivery and reduce geographic disparities.
A new examination of remoteness as a barrier to health care, published online today in the Journal of Global Health, notes that most surveys and policy documents categorize families as living either in an urban or rural setting, and this dichotomy can mask disparities ...
When it comes to the art of persuasion, you can attract more followers if you turn conventional wisdom on its head and stress what you like, not what you do.
A new study, to be published in an upcoming issue of the Journal of Personality and Social Psychology, finds that people are more likely to conform to others' preferences than conform to others' actions. In other words, people want to like what others like, but they want to have or do what others don't have or don't do.
In the study, "Words Speak Louder: Conforming to Preferences More Than Actions," by University ...
DURHAM, N.C. - Researchers at Duke University School of Medicine and Brigham and Women's Hospital, Harvard Medical School have identified a mechanism that explains why some mutations can be disease-causing in one genome but benign in another.
In a study appearing June 29, 2015, in the journal Nature, the researchers compared thousands of human disease-causing mutations with the analogous sequences of some 100 animal species. They discovered non-human genomes carrying mutations that cause severe disease in humans, yet were benign in the animals.
Although generally in ...
The brown marmorated stink bug has a bad reputation. And for good reason: every summer, this pest attacks crops and invades homes, causing both sizable economic losses and a messy, smelly nuisance--especially in the eastern United States. A new study by entomologists at the University of Maryland shows that these pests, known simply as stink bugs, have a strong preference for ripe fruit. Moreover, stink bugs track their favorite fruits throughout the growing season in an effort to maximize their access to food.
The study, published online June 25, 2015 in the Journal ...
PHILADELPHIA -- Since their discovery in the 1950s, transfer RNAs (tRNAs) have been best known for their role in helping the cell make proteins from messenger RNA templates. However, recent studies have led to a previously-unsuspected concept that tRNAs are not always the end product; namely, they further serve as a source of small RNAs. Now researchers have discovered a new species of tRNA-derived small RNAs that are produced only in hormonally-driven breast and prostate cancers, and which contribute to cell proliferation. The results will be published online the week ...
The warm temperature on a summer's day is often a time for relaxing, but researchers from the University of Leicester have suggested that a 'thermosensory' gene could be responsible for changes in behaviour in different climates.
The researchers from the University of Leicester's Department of Genetics have explored how the biological clock can be affected by the environment by examining the fruitfly Drosophila melanogaster, which shows 24 hour biological cycles and is used as a model organism for studies into human rhythms.
Like many humans, the fly has a 'siesta' ...
